Amorepacific Group Reports 137.8 Billion Won Operating Profit in Q1, Up 6.9% Year-on-Year

Sales Up 5% to 1.2227 Trillion Won... High Growth Driven by Aestura and COSRX

Amorepacific's Operating Profit Reaches 126.7 Billion Won, Up 7.6%

Profitability Improves Domestically, Investment Expands Overseas... Weakness in Greater China Remains a Concern

Amorepacific Group announced on April 29 that it recorded consolidated sales of 1.2227 trillion won and an operating profit of 137.8 billion won for the first quarter of 2026. This represents increases of 5% and 6.9%, respectively, compared to the same period last year.

This performance was driven by the rapid growth of domestic and international derma beauty brands such as Aestura, COSRX, Illiyoon, and IOPE, expansion of its North American Amazon business, growth of major brands in the Japanese market, and improved profitability in its domestic business.

Exterior view of the Amorepacific headquarters building.

Amorepacific, the Group's main subsidiary, posted sales of 1.1358 trillion won and operating profit of 126.7 billion won, up 6.4% and 7.6%, respectively, year-on-year.

In global markets, key brands including Aestura, COSRX, and Laneige continued strong growth, particularly in North America, Europe, and Japan. Notably, Aestura achieved triple-digit growth in North America, COSRX rebounded thanks to its performance on Amazon, and Laneige further solidified its global presence with new product launches.

In Korea, sales rose 9% and operating profit surged 65%, resulting in a significant improvement in profitability. This was driven by balanced growth across major brands and sales channels. Sulwhasoo, Hera, and Laneige saw increased sales through both online and offline channels as well as multi-brand store (MBS) channels. Aestura achieved record-high sales at Olive Young, and Mise-en-Scene performed well in new channels such as TikTok Shop.

Overseas sales increased by 6%, but operating profit declined due to expanded marketing investments. The company continued to post double-digit sales growth in Western markets, Japan, and the Asia-Pacific (APAC) region. In North America and Europe, COSRX, Aestura, and Innisfree led the growth, while in Japan and Southeast Asia, Laneige and derma brands recorded strong results. However, sales in the Greater China region decreased due to offline efficiency improvements.

Brands such as Innisfree, Etude, and Espoir saw declines in both sales and operating profit due to restructuring of offline channels. In contrast, Osulloc contributed to improved performance among affiliates by strengthening its premium tea brand and expanding its dessert lineup.

An Amorepacific spokesperson said, "The high growth of the Group's leading derma brands both domestically and abroad, the expansion of our Amazon business in North America, strong growth of major brands in the Japanese market, and increased sales and improved profitability in our domestic business drove our first-quarter results."

This content was produced with the assistance of AI translation services.